|
|
||||||||
Clinical Observations |
1 Department of Radiology, Mayo Clinic, 200 1st St., SW, Rochester, MN
55902.
2 Present address: St. Paul Radiology, St. Paul, MN.
3 Department of Internal Medicine, Endocrinology Division, Mayo Clinic,
Rochester, MN.
4 Department of Surgery, Division of Gastroenterologic and General Surgery, Mayo
Clinic, Rochester, MN.
OBJECTIVE. The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy.
CONCLUSION. Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.
Keywords: alcohol ablation ethanol ablation hypercalcemia hyperparathyroidism multiple endocrine neoplasia syndrome parathyroid gland
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |